PDUFA Application Fee Nears $3m Threshold In FY 2020
Executive Summary
The US FDA fee for a new drug or biologics license application requiring clinical data will jump to $2.94m in October.
You may also be interested in...
A More Perfect Meeting: Industry Seeks Additional PDUFA VII Metrics To Improve Communications
Will the US FDA agree to more structured communications amid its struggles with the existing meeting workload?
PDUFA Needs More Than 300 Additional FTEs, New US FDA Capacity Planning Formula Says
But the agency chose to fund only a small fraction of them, in part because of its hiring ability, and in part because all those employees would have cost an additional $98.7m in user fee revenue.
Surprise! PDUFA Fees Dropping In FY 2021
A more than 2% drop for NDAs and BLAs in FY 2021, while program fees will increase more than 3%.